Peptides DB
Research-centric peptide and protocol reference hub
Study 12 of 21Humanin literatureExperimental physiology · Animal study · Preclinical2026

Humanin ameliorates diabetes-induced testicular damage in a streptozotocin-induced mouse model.

Humanin treatment improved oxidative stress markers and testicular tissue health in a diabetic mouse model, but further studies are needed to confirm these effects in humans.

Read at Experimental physiologyAdd to compare

Where it sits

this study against the rest of the humanin corpus
6
Preclinical · this one
13
Observational
0
Open-label
0
Randomised
2
Reviews

Summary and findings

This study investigated the effects of humanin on oxidative stress parameters and histopathological alterations in testicular tissue in a streptozotocin-induced diabetic mouse model. A total of 40 adult male Balb/C mice were used, with humanin administered at a dose of 4 mg/kg for 15 days following diabetes induction. The study found significant changes in oxidative stress markers and histopathological improvements in testicular tissues following treatment.

How much of this paper we could read: full text read (0.80). We had a clear abstract, so the summary below closely tracks the paper. What this means →
P < 0.05 for TAS and GSH levels in seminal vesicle fluid.Preclinical2026

Abstract

The authors’ words, as Experimental physiology supplied them

Diabetes mellitus is a major metabolic disorder closely associated with oxidative stress and male reproductive dysfunction. Humanin, a mitochondria-derived peptide, has been reported to exert cytoprotective, anti-apoptotic and antioxidant effects in various disease models; however, its role in diabetes-induced testicular damage remains unclear. This study aimed to investigate the effects of humanin on oxidative stress parameters in seminal vesicle fluid and histopathological alterations in testicular tissue in a streptozotocin (STZ)-induced diabetic mouse model. A total of 40 adult male Balb/C mice were randomly assigned into four groups: Control, Humanin (HN), STZ, and STZ+HN (n = 10 per group). Diabetes was induced via intraperitoneal administration of STZ (150 mg/kg). Humanin (4 mg/kg) was administered intraperitoneally for 15 days following diabetes induction. Total antioxidant status (TAS), total oxidant status (TOS), and glutathione (GSH) levels in seminal vesicle fluid were measured using ELISA. Testicular tissues were evaluated histopathologically and histomorphometrically. STZ-induced diabetes resulted in a significant decrease in TAS and GSH levels and an increase in TOS levels in seminal vesicle fluid (P < 0.05). Humanin treatment significantly increased TAS and GSH levels while reducing TOS levels compared to the STZ group (P < 0.05). Histopathological analysis demonstrated seminiferous tubule degeneration, germ cell loss, interstitial oedema, and vascular congestion in diabetic mice, whereas these alterations and associated histomorphometric abnormalities were significantly ameliorated following humanin treatment. Humanin attenuated diabetes-induced oxidative imbalance and testicular histopathological damage in STZ-induced diabetic mice. These findings suggest that humanin may exert protective effects against diabetes-associated testicular injury. Further studies are required to elucidate the underlying molecular mechanisms and validate these findings in broader experimental settings.

Background

The paper addresses the impact of diabetes on testicular health, which is a recognized concern in diabetic patients. Prior research has indicated that diabetes can lead to reproductive complications, but the role of Humanin in this context had not been extensively studied. This research is significant as it explores a potential protective mechanism against diabetes-induced reproductive damage.

Methods

The study utilized a streptozotocin-induced mouse model to simulate diabetes. The specific number of mice (n) used, the dosage of Humanin administered, and the duration of treatment were not reported in the abstract. Primary and secondary outcome measures were also not specified.

Results

Not reported in abstract.

Interpretation

Without specific results, it is challenging to compare these findings to existing literature or to assess the clinical significance of the observed effects. The lack of detailed statistical data limits the ability to draw firm conclusions about the efficacy of Humanin in this model. Any implications for practice remain speculative until more robust data are available.

Key findings

  • Not reported in abstract.

Limitations

  • rodent model, may not translate to humans
  • specific numeric outcomes not reported
  • lack of detailed statistical analysis

Elsewhere in the Humanin corpus

CStructural mechanism governing the directionality of bridge recombination.Nature · 2026 · Not reported in abstract.In vitroAEffectiveness of WeChat-based interventions for glycemic control in patients with diabetes mellitus: A systematic review and meta-analysis.Journal of diabetes and metabolic disorders · 2026 · n=1742 · MD -1.10% HbA1c, 95% CI -1.78 to -0.42; I² = 85%; n=1742.reviewCScaled Multidimensional Assays of Variant Effect Identify Sequence-Function Relationships in Hypertrophic Cardiomyopathy.Circulation · 2026 · Not reported in abstract.In vitroCHuman pancreatic ductal cells from non-diabetic donors function as non-professional antigen-presenting cells upon inflammatory cytokine exposure.Diabetologia · 2026 · Not reported in abstract.In vitroBDevelopment of a theory-based provider-focused training to improve HPV vaccine recommendations for young adults.Human vaccines & immunotherapeutics · 2026 · n=15 · Not reported in abstract.HumanBSerum Index for Malignant Pleural Effusion (SIMPLE): A non-invasive, blood-based prognostic score for patients with newly diagnosed and relapsing MPE.Pulmonology · 2026 · n=678 · SIMPLE AUC = 0.852 (95% CI 0.782-0.921).Human